文献速递心血管介入MR

立体定向消融放射治疗(SABR)用于心律失常:一种新的治疗选择?

Stereotactic Ablative radiation therapy (SABR) for cardiac arrhythmia: A new therapeutic option?
PubMed 文献 · Radiol Med · 2020-05-13

本文综述了SABR治疗心律失常的临床前与早期临床证据及未来方向,通过Pubmed检索和ClinicalTrials.gov进行综述。动物模型显示SABR可能是一种安全有效的无创治疗方法,中位反应时间约2-3个月;临床数据(病例系列、病例报告和早期前瞻性研究)已提示SABR(单次25 Gy)治疗难治性室性心律失常的可行性、疗效和安全性。

要点

  • 动物模型显示SABR治疗心律失常的中位反应时间约2-3个月,房室结似乎比其他心脏电活动区域更放射敏感。
  • 已发表的病例系列、病例报告和早期前瞻性研究提示SABR(单次25 Gy)治疗难治性室性心律失常的可行性、疗效和安全性。
  • 正在进行的SABR试验及放疗技术(如混合磁共振)和心律失常无创标测系统的进步,未来分析将提高这些初步结果的可靠性。

诊断标准与关键数值

  • 动物模型显示SABR治疗心律失常的中位反应时间约2-3个月。
  • 临床数据提示SABR(单次25 Gy)用于难治性室性心律失常具有可行性、疗效和安全性。

临床应用与阅片要点

  • 作者指出,鉴于正在进行的SABR试验以及放疗技术(如混合磁共振)和心律失常无创标测系统的进步,未来分析将提高这些初步结果的可靠性。

局限性

  • 原文指出未来分析将提高这些初步结果的可靠性,提示当前证据为初步结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: Stereotactic ablative radiation therapy (SABR) is used in non-oncologic indications, recently even for cardiac arrhythmias. Thus, aim of this analysis is to review preclinical, early clinical evidences and future direction of the latter new treatment approach.

METHOD: A collection of available data regarding SABR and cardiac arrhythmias was made, by Pubmed research and 2 independent researchers, including preclinical and clinical data. A review of ongoing trials was conducted on ClinicalTrials.gov.

RESULTS: Preclinical research conducted in animal models showed that a safe and effective noninvasive treatment approach for cardiac arrhythmias could be represented by SABR with a median time of response around 2-3 months. The treatment dose plays a crucial role: the atrioventricular node would seem more radiosensitive than the other cardiac electric zones. Clinical data, such as published case series, case reports and early prospective studies, have already suggested the feasibility, efficacy and safety of SABR (25 Gy in one session) for refractory ventricular arrhythmias.

CONCLUSION: Considering the ongoing trials of SABR and new technological improvements in radiotherapy (e.g. hybrid magnetic resonance) and in arrhythmias noninvasive mapping systems, the future analyses will improve the reliability of those preliminary results.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Fiorentino A, Gregucci F, Bonaparte I, et al. Stereotactic Ablative radiation therapy (SABR) for cardiac arrhythmia: A new therapeutic option? Radiol Med. 2020. PMID: 32405924. doi:10.1007/s11547-020-01218-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。